Detection method of L-tryptophan methyl ester hydrochloride in D-tryptophan methyl ester hydrochloride

Through high performance liquid chromatography combined with chiral chromatography column and specific mobile phase, the problem of L-tryptophan methyl ester hydrochloride residue in D-tryptophan methyl ester hydrochloride is solved, achieving efficient separation and detection , improves the purity and production efficiency of tadalafil preparation.

CN114839308BActive Publication Date: 2024-12-03JIANGSU TASLY DIYI PHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202110133199.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-01-30
Publication Date
2024-12-03
Estimated Expiration
2041-01-30

AI Technical Summary

Technical Problem

The possible presence of L-tryptophan methyl ester hydrochloride residues in existing D-tryptophan methyl ester hydrochloride is not conducive to the preparation of tadalafil, and an efficient detection method is required to eliminate L-color as much as possible. Methyl amino acid hydrochloride.

Method used

Using high performance liquid chromatography, the Chiralpak IC was used to calculate the content of impurity peaks using a chiral chromatography column, and the mobile phase was n-hexane-ethanol-diethylamine or n-hexane-isopropanol-diethylamine. The binding area normalization method was used to calculate the content of impurity peaks. Ensure the isolation and detection of L-tryptophan methyl ester hydrochloride in D-tryptophan methyl ester hydrochloride.

Benefits of technology

Effective separation and detection of L-tryptophan methyl ester hydrochloride in D-tryptophan methyl ester hydrochloride is achieved, which improves the purity and production efficiency of the preparation process and ensures the quality of tadalafil.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114839308B_ABST
    Figure CN114839308B_ABST
Patent Text Reader

Abstract

The invention relates to a method for detecting L-tryptophan methyl ester hydrochloride in D-tryptophan methyl ester hydrochloride. The method adopts a high performance liquid chromatography method. The method comprises the following steps: step 1, preparation of a test solution: taking an appropriate amount of a D-tryptophan methyl ester hydrochloride sample, adding a n-hexane-ethanol mixed solvent, preparing a solution as the test solution; step 2, preparation of an impurity localization solution: taking an L-tryptophan methyl ester hydrochloride standard, adding a mobile phase to prepare a solution as a chiral impurity localization solution; step 3, determination method: measuring the chiral impurity localization solution and the test solution, and injecting them into a liquid chromatograph respectively; step 4, if the test solution has an impurity peak at the L-tryptophan methyl ester hydrochloride, calculating the content thereof by an area normalization method.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a drug detection method, in particular to a detection method for L-tryptophan methyl ester hydrochloride in D-tryptophan methyl ester hydrochloride. Background Art

[0002] D-Tryptophan methyl ester hydrochloride is an important raw material for the synthesis of tadalafil (as shown below).

[0003]

[0004] D-Tryptophan methyl ester hydrochloride has the following structural formula:

[0005]

[0006] The CAS number is 14907-27-8,

[0007] The molecular formula is C12H15ClN2O2,

[0008] Melting point: 213-216℃,

[0009] Storage conditions: 2-8℃,

[0010] Water solubility: soluble in water (150 mg / ml), DMF (50 mg / ml).

[0011] The existing preparation method of D-tryptophan methyl ester hydrochloride is as follows: D-tryptophan (50g) is added to a mixed solution of toluene (650ml) and methanol (105ml) and stirred evenly, thionyl chloride (38.6g) is slowly added dropwise at 0 degrees Celsius, and after the addition is completed, the temperature is raised to 75-80 degrees Celsius and refluxed for 4 hours, and the reaction is completed. The reaction solution is cooled to 0 degrees Celsius and stirred for 2 hours, solids are precipitated, filtered, the filter cake is washed with toluene, and vacuum dried at 50 degrees Celsius for 6 hours to obtain D-tryptophan methyl ester hydrochloride, a white powder solid. The yield is 95%, and the HPLC purity is 99%.

[0012] D-tryptophan methyl ester hydrochloride is an optical isomer. During the preparation process, the isomer L-tryptophan methyl ester hydrochloride may remain. The presence of this isomer is very unfavorable for the further preparation of tadalafil. Therefore, it is necessary to eliminate as much L-tryptophan methyl ester hydrochloride in D-tryptophan methyl ester hydrochloride as possible. To this end, it is first necessary to study the detection method of L-tryptophan methyl ester hydrochloride in D-tryptophan methyl ester hydrochloride. The present invention obtains a detection method after research. Summary of the invention

[0013] A method for detecting L-tryptophan methyl ester hydrochloride in D-tryptophan methyl ester hydrochloride, the method adopts high performance liquid chromatography, the method comprises the following steps:

[0014] Step 1, preparation of the test solution: take an appropriate amount of D-tryptophan methyl ester hydrochloride sample, add n-hexane-ethanol mixed solvent to prepare a solution as the test solution.

[0015] Step 2, preparation of impurity localization solution: Take L-tryptophan methyl ester hydrochloride standard, add mobile phase to prepare a solution, which is used as chiral impurity localization solution.

[0016] Step 3, determination method: measure the chiral impurity localization solution and the test sample solution, and inject them into the liquid chromatograph respectively;

[0017] Step 4: If there is an impurity peak at L-tryptophan methyl ester hydrochloride in the test solution, calculate its content by the area normalization method.

[0018] The HPLC conditions are as follows:

[0019] Instrument: High performance liquid chromatography

[0020] Chromatographic column: Chiralpak IC

[0021] Mobile phase: n-hexane-C1~C3 lower alcohol-diethylamine, the ratio is 60~75:25~40:0.1

[0022] Detection wavelength: 280-290nm

[0023] Flow rate: 0.8-1.2mL / min

[0024] Column temperature: 30-40℃

[0025] Injection volume: 5-30μL

[0026] In the mobile phase of the present invention, C1-C3 lower alcohol refers to a monovalent straight-chain alcohol or a branched-chain alcohol having 1 to 3 carbon atoms, such as methanol, ethanol, propanol, isopropanol, and the like.

[0027] In the mobile phase of the present invention, the C1-C3 lower alcohol is selected from ethanol or isopropanol.

[0028] More preferably, the mobile phase of the present invention is n-hexane-ethanol-diethylamine in a ratio of 75:25:0.1.

[0029] Alternatively, the mobile phase of the present invention is n-hexane-isopropanol-diethylamine in a ratio of 60:40:0.1.

[0030] The detection wavelength is preferably 285 nm.

[0031] The flow rate is preferably 1 mL / min.

[0032] The column temperature is preferably 35°C.

[0033] The experimental steps of the present invention are further preferably:

[0034] Step 1, preparation of test solution

[0035] Take an appropriate amount of D-tryptophan methyl ester hydrochloride sample and add a 1:1 volume ratio of n-hexane-ethanol mixed solvent to make a solution containing 0.4-0.6 mg per 1 ml as the test solution;

[0036] Step 2, preparation of reference solution

[0037] Take L-tryptophan methyl ester hydrochloride standard, add mobile phase to dissolve and dilute to make a solution containing 0.04-0.06 mg per 1 ml, which is used as the chiral impurity location solution;

[0038] Step 3, Detection

[0039] Accurately measure 15-25 μl of the chiral impurity location solution and the test sample solution, respectively, and inject them into the liquid chromatograph, and record the chromatogram to 1.5-2.5 times the retention time of the main component peak.

[0040] Step 4, calculate

[0041] If there is an impurity peak at L-tryptophan methyl ester hydrochloride in the test solution, calculate the content of L-tryptophan methyl ester hydrochloride by the area normalization method.

[0042] Most preferably, the detection method of the present invention comprises the following steps:

[0043] Step 1, preparation of test solution

[0044] Take an appropriate amount of D-tryptophan methyl ester hydrochloride sample and add a 1:1 volume ratio of n-hexane-ethanol mixed solvent to make a solution containing 0.5 mg per 1 ml as the test solution;

[0045] Step 2, preparation of reference solution

[0046] Take L-tryptophan methyl ester hydrochloride standard, add mobile phase to dissolve and dilute to make a solution containing 0.05 mg per 1 ml, which is used as the chiral impurity location solution;

[0047] Step 3, Detection

[0048] Accurately measure 20 μl of chiral impurity localization solution and test solution, respectively, and inject them into the liquid chromatograph, and record the chromatogram until twice the retention time of the main component peak;

[0049] Step 4, calculate

[0050] If there is an impurity peak at L-tryptophan methyl ester hydrochloride in the test solution, calculate the content of L-tryptophan methyl ester hydrochloride by the area normalization method;

[0051] The chromatographic conditions are as follows:

[0052] A chiral chromatographic column Chiralpak IC, 5 μm, 4.6 mm×250 mm, was used, with n-hexane-ethanol-diethylamine in a ratio of 75:25:0.1 as the mobile phase, a flow rate of 1.0 ml per minute, a column temperature of 35° C., and a detection wavelength of 285 nm.

[0053] Alternatively, the steps are as follows:

[0054] Step 1, preparation of test solution

[0055] Take an appropriate amount of D-tryptophan methyl ester hydrochloride sample and add a 1:1 volume ratio of n-hexane-ethanol mixed solvent to make a solution containing 0.5 mg per 1 ml as the test solution;

[0056] Step 2, preparation of reference solution

[0057] Take L-tryptophan methyl ester hydrochloride standard, add mobile phase to dissolve and dilute to make a solution containing 0.05 mg per 1 ml, which is used as the chiral impurity location solution;

[0058] Step 3, Detection

[0059] Accurately measure 20 μl of chiral impurity localization solution and test solution, respectively, and inject them into the liquid chromatograph, and record the chromatogram until twice the retention time of the main component peak;

[0060] Step 4, calculate

[0061] If there is an impurity peak at L-tryptophan methyl ester hydrochloride in the test solution, calculate the content of L-tryptophan methyl ester hydrochloride by the area normalization method;

[0062] The chromatographic conditions are as follows:

[0063] A chiral chromatographic column Chiralpak IC, 5 μm, 4.6 mm×250 mm, was used, with n-hexane-isopropanol-diethylamine in a ratio of 60:40:0.1 as the mobile phase, a flow rate of 1.0 ml per minute, a column temperature of 35° C., and a detection wavelength of 285 nm.

[0064] Wherein, in the present invention, D-tryptophan methyl ester hydrochloride is purchased from the market or prepared according to the prior art.

[0065] The L-tryptophan methyl ester hydrochloride standard product is high-purity L-tryptophan methyl ester hydrochloride, generally more than 98%, which can be purchased from the market or prepared according to the prior art.

[0066] The chromatographic conditions of the present invention are obtained through screening, and the screening process is as follows:

[0067] The inventors of the present invention first tried to explore the chromatographic column, and the chromatographic conditions were as follows:

[0068] A chiral chromatographic column Chiralpak ZWIX(+) (3 μm, 3 mm×150 mm) was used, with methanol-acetonitrile-water (20:80:2) as the mobile phase (containing 50 mM formic acid and 25 mM diethylamine), a column temperature of 25° C., and a flow rate of 0.4 ml / min.

[0069] Results: The two chromatographic peaks of D-tryptophan methyl ester hydrochloride and L-tryptophan methyl ester hydrochloride did not reach baseline separation, and the resolution was poor (see Figure 1 ).

[0070] Therefore, the inventors selected Chiralpak IC (5 μm, 4.6 mm × 250 mm) chromatographic column and optimized and screened the mobile phase.

[0071] Chromatographic conditions 1 are as follows:

[0072] Chromatographic column: Chiralpak IC, 5μm, 4.6mm×250mm

[0073] Mobile phase: n-hexane-isopropanol (60:40)

[0074] Column temperature: 35°C

[0075] Flow rate: 1.0ml / min

[0076] Results: 1. The peak order is: D-tryptophan methyl ester hydrochloride, L-tryptophan methyl ester hydrochloride.

[0077] 2. The chromatographic peaks of D-tryptophan methyl ester hydrochloride and L-tryptophan methyl ester hydrochloride were poor in shape and had severe tailing (see the results). Figure 2 ).

[0078] Chromatographic conditions 2 are as follows:

[0079] Chromatographic column: Chiralpak IC, 5μm, 4.6mm×250mm

[0080] Mobile phase: n-hexane-ethanol (50:50)

[0081] Column temperature: 35°C

[0082] Flow rate: 1.0ml / min

[0083] Results: 1. The peak order is: D-tryptophan methyl ester hydrochloride, L-tryptophan methyl ester hydrochloride.

[0084] 2. The chromatographic peaks of D-tryptophan methyl ester hydrochloride and L-tryptophan methyl ester hydrochloride appeared earlier and were interfered by the solvent peak.

[0085] 3. The chromatographic peaks of D-tryptophan methyl ester hydrochloride and L-tryptophan methyl ester hydrochloride were poor in shape and had severe tailing (see the results). Figure 3 ).

[0086] Chromatographic conditions 3 are as follows:

[0087] Chromatographic column: Chiralpak IC, 5μm, 4.6mm×250mm

[0088] Mobile phase: n-hexane-ethanol (75:25)

[0089] Column temperature: 35°C

[0090] Flow rate: 1.0ml / min

[0091] Results: 1. The peak order is: D-tryptophan methyl ester hydrochloride, L-tryptophan methyl ester hydrochloride, and the retention time is appropriate.

[0092] 2. The chromatographic peaks of D-tryptophan methyl ester hydrochloride and L-tryptophan methyl ester hydrochloride were severely tailed (see the results). Figure 4 ).

[0093] Chromatographic conditions 4 are as follows:

[0094] Chromatographic column: Chiralpak IC, 5μm, 4.6mm×250mm

[0095] Mobile phase: n-hexane-isopropanol-diethylamine (60:40:0.1)

[0096] Column temperature: 35°C

[0097] Flow rate: 1.0ml / min

[0098] Results: 1. The peak order is: D-tryptophan methyl ester hydrochloride, L-tryptophan methyl ester hydrochloride.

[0099] 2. The chromatographic peaks of D-tryptophan methyl ester hydrochloride and L-tryptophan methyl ester hydrochloride are good.

[0100] 3. The chromatographic peak separation between D-tryptophan methyl ester hydrochloride and L-tryptophan methyl ester hydrochloride meets the requirements (see the results). Figure 5 ).

[0101] Chromatographic conditions 5 are as follows:

[0102] Chromatographic column: Chiralpak IC, 5μm, 4.6mm×250mm

[0103] Mobile phase: n-hexane-ethanol-diethylamine (75:25:0.1)

[0104] Column temperature: 35°C

[0105] Flow rate: 1.0ml / min

[0106] Results: 1. The peak order is: D-tryptophan methyl ester hydrochloride, L-tryptophan methyl ester hydrochloride.

[0107] 2. The chromatographic peaks of D-tryptophan methyl ester hydrochloride and L-tryptophan methyl ester hydrochloride are good.

[0108] 3. The chromatographic peak separation between D-tryptophan methyl ester hydrochloride and L-tryptophan methyl ester hydrochloride meets the requirements (see the results). Figure 6 ).

[0109] Therefore, the detection method of L-tryptophan methyl ester hydrochloride in D-tryptophan methyl ester hydrochloride of the present invention, the most preferred chromatographic conditions are:

[0110] Chromatographic column: Chiralpak IC, 5μm, 4.6mm×250mm

[0111] Mobile phase: n-hexane-isopropanol-diethylamine (60:40:0.1)

[0112] Column temperature: 35°C

[0113] Flow rate: 1.0ml / min

[0114] Detection wavelength: 285nm

[0115] or

[0116] Chromatographic column: Chiralpak IC, 5μm, 4.6mm×250mm

[0117] Mobile phase: n-hexane-ethanol-diethylamine (75:25:0.1)

[0118] Column temperature: 35°C

[0119] Flow rate: 1.0ml / min

[0120] Detection wavelength: 285nm

[0121] The method of the present invention has been verified by methodology:

[0122] Chiralpak IC, 5μm, 4.6mm×250mm chromatographic column, n-hexane-ethanol-diethylamine (75:25:0.1) as mobile phase, flow rate of 1.0ml per minute, column temperature of 35℃, detection wavelength of 285nm, the test solution of this method was tested, and the method validation results are as follows:

[0123] System suitability test

[0124] A test solution containing 0.5% L-tryptophan methyl ester hydrochloride was prepared and injected continuously for 6 times according to the analytical method. The RSD of the peak area of ​​L-tryptophan methyl ester hydrochloride was 0.62%, and the RSD of the peak area of ​​D-tryptophan methyl ester hydrochloride was 0.14%, indicating that the system had good applicability.

[0125] Specificity test

[0126] Table 1: Results of single and mixed injection of D-tryptophan methyl ester hydrochloride, L-tryptophan methyl ester hydrochloride and D-tryptophan

[0127]

[0128]

[0129] The results showed that the method had good specificity.

[0130] Repeatability test

[0131] According to the analytical method, 6 test solutions were prepared and the content of isomer L-tryptophan methyl ester hydrochloride was determined. No isomer was detected in 6 samples, indicating that the method has good repeatability.

[0132] Solution stability test

[0133] Prepare 1 portion of the test solution, place it at room temperature for 12 hours, and inject it once every 1 hour. Calculate the content of L-tryptophan methyl ester hydrochloride by normalization method. The results show that D-tryptophan methyl ester hydrochloride solution has good stability at room temperature, and L-tryptophan methyl ester hydrochloride was not detected in any sample.

[0134] Detection limit

[0135] Take an appropriate amount of L-tryptophan methyl ester hydrochloride, add mobile phase to dilute it to make a solution of about 20 μg / mL, and gradually dilute it to low concentrations. The concentration when the signal-to-noise ratio is about 3 is used as the detection limit.

[0136] Table 2: Detection limit determination results

[0137]

[0138] The results showed that this method had good detection sensitivity.

[0139] Summary of the results of the validation of the L-tryptophan methyl ester hydrochloride test methodology

[0140] Table 3: Method validation summary

[0141]

[0142] The detection method of the present invention can completely separate L-tryptophan methyl ester hydrochloride from D-tryptophan methyl ester hydrochloride, and the method has good specificity and sensitivity, and can be completely used for the detection of L-tryptophan methyl ester hydrochloride in D-tryptophan methyl ester hydrochloride in the actual production process. BRIEF DESCRIPTION OF THE DRAWINGS

[0143] Figure 1 This is a chromatogram of a Chiralpak ZWIX(+) chromatographic column used in the experimental screening process of the present invention.

[0144] Figure 2 This is a chromatogram of the Chiralpak IC chromatographic column used in the experimental screening process of the present invention, with n-hexane-isopropanol (60:40) as the mobile phase.

[0145] Figure 3 This is a chromatogram of a Chiralpak IC chromatographic column and n-hexane-ethanol (50:50) as the mobile phase in the experimental screening process of the present invention.

[0146] Figure 4 This is a chromatogram of a Chiralpak IC chromatographic column and n-hexane-ethanol (75:25) as the mobile phase in the experimental screening process of the present invention.

[0147] Figure 5 This is a chromatogram of a Chiralpak IC chromatographic column and a mobile phase of n-hexane-isopropanol-diethylamine (60:40:0.1) used in the experimental screening process of the present invention.

[0148] Figure 6 The chromatogram of the Chiralpak IC chromatographic column used in the experimental screening process of the present invention and the mobile phase using n-hexane-ethanol-diethylamine (75:25:0.1).

[0149] Figure 7 It is a high performance liquid chromatogram of Example 1 of the present invention.

[0150] Figure 8 It is the high performance liquid chromatogram of Example 2 of the present invention. DETAILED DESCRIPTION

[0151] The present invention is further illustrated by the following examples.

[0152] Example 1

[0153] Step 1, preparation of test solution:

[0154] Take an appropriate amount of D-tryptophan methyl ester hydrochloride sample purchased from the market, add diluent [n-hexane-ethanol (1:1)] to dissolve and dilute to make a solution containing about 0.5 mg per 1 ml, as the test solution;

[0155] Step 2, Chiral Impurity Location Solution

[0156] Take L-tryptophan methyl ester hydrochloride standard, add mobile phase to dissolve and dilute to make a solution containing about 0.05 mg per 1 ml, which is used as the chiral impurity location solution;

[0157] Step 3, Detection

[0158] Accurately measure 20 μl of chiral impurity localization solution and test solution, respectively, and inject them into the liquid chromatograph, and record the chromatogram until twice the retention time of the main component peak;

[0159] Step 4, calculate

[0160] If there is an impurity peak at L-tryptophan methyl ester hydrochloride in the test solution, it shall not be greater than 0.5% calculated by the area normalization method.

[0161] The chromatographic conditions are as follows:

[0162] A chiral chromatographic column (Chiralpak IC, 5 μm, 4.6 mm×250 mm) was used with n-hexane-ethanol-diethylamine (75:25:0.1) as the mobile phase, a flow rate of 1.0 ml per minute, a column temperature of 35° C., and a detection wavelength of 285 nm.

[0163] Results The content of L-tryptophan methyl ester hydrochloride was not detected.

[0164] The chromatogram of the test results is shown in Figure 7 .

[0165] Example 2

[0166] Step 1, preparation of test solution:

[0167] Take an appropriate amount of D-tryptophan methyl ester hydrochloride sample purchased from the market, add diluent [n-hexane-ethanol (1:1)] to dissolve and dilute to make a solution containing about 0.5 mg per 1 ml, as the test solution;

[0168] Step 2, Chiral Impurity Location Solution

[0169] Take L-tryptophan methyl ester hydrochloride standard, add mobile phase to dissolve and dilute to make a solution containing about 0.05 mg per 1 ml, which is used as the chiral impurity location solution;

[0170] Step 3, Detection

[0171] Accurately measure 20 μl of chiral impurity localization solution and test solution, respectively, and inject them into the liquid chromatograph, and record the chromatogram until twice the retention time of the main component peak;

[0172] Step 4, calculate

[0173] If there is an impurity peak at L-tryptophan methyl ester hydrochloride in the test solution, it shall not be greater than 0.5% calculated by the area normalization method.

[0174] The chromatographic conditions are as follows:

[0175] A chiral chromatographic column (Chiralpak IC, 5 μm, 4.6 mm×250 mm) was used with n-hexane-isopropanol-diethylamine (60:40:0.1) as the mobile phase, a flow rate of 1.0 ml per minute, a column temperature of 35°C, and a detection wavelength of 285 nm.

[0176] Results The content of L-tryptophan methyl ester hydrochloride was not detected.

[0177] The chromatogram of the test results is shown in Figure 8 .

Claims

1. A method for detecting L-tryptophan methyl ester hydrochloride in D-tryptophan methyl ester hydrochloride, the method adopting high performance liquid chromatography, It is characterized in that The method comprises the following steps: Step 1, preparation of the test solution: take an appropriate amount of D-tryptophan methyl ester hydrochloride sample, add a 1:1 volume ratio of n-hexane-ethanol mixed solvent to make a solution containing 0.4-0.6 mg per 1 ml, as the test solution; Step 2, preparation of impurity localization solution: take L-tryptophan methyl ester hydrochloride standard, add mobile phase to dissolve and dilute to make a solution containing 0.04-0.06 mg per 1 ml, as chiral impurity localization solution; Step 3, determination method: measure the chiral impurity localization solution and the test sample solution, and inject them into the liquid chromatograph respectively; Step 4, if there is an impurity peak at L-tryptophan methyl ester hydrochloride in the test solution, calculate its content by area normalization method; The HPLC conditions are as follows: Instrument: High performance liquid chromatography Chromatographic column: Chiralpak IC Mobile phase: n-hexane-C1-C3 lower alcohol-diethylamine, ratio 60-75:25-40:0.1 Detection wavelength: 280-290nm Flow rate: 0.8-1.2mL / min Column temperature: 30-40℃ Injection volume: 5-30μL.

2. The method according to claim 1, It is characterized in that In the mobile phase, the C1-C3 lower alcohol is selected from ethanol or isopropanol.

3. The method according to claim 2, It is characterized in that The mobile phase is: n-Hexane-ethanol-diethylamine, the ratio is 75:25:0.

1.

4. The method according to claim 2, It is characterized in that The mobile phase is: n-Hexane-isopropanol-diethylamine, the ratio is 60:40:0.

1.

5. The method according to claim 1, It is characterized in that In the chromatographic conditions, Detection wavelength: 285nm; Flow rate: 1mL / min Column temperature: 35°C.

6. The method according to claim 1, It is characterized in that in, Step 3, detection, the method is as follows: Accurately measure 15-25 μl of the chiral impurity location solution and the test sample solution, respectively, and inject them into the liquid chromatograph, and record the chromatogram to 1.5-2.5 times the retention time of the main component peak.

7. The method according to claim 1, It is characterized in that The method comprises the following steps: Step 1, preparation of test solution Take an appropriate amount of D-tryptophan methyl ester hydrochloride sample and add a 1:1 volume ratio of n-hexane-ethanol mixed solvent to make a solution containing 0.5 mg per 1 ml as the test solution; Step 2, preparation of reference solution Take L-tryptophan methyl ester hydrochloride standard, add mobile phase to dissolve and dilute to make a solution containing 0.05 mg per 1 ml, which is used as the chiral impurity location solution; Step 3, Detection Accurately measure 20 μl of chiral impurity localization solution and test solution, respectively, and inject them into the liquid chromatograph, and record the chromatogram until twice the retention time of the main component peak; Step 4, calculate If there is an impurity peak at L-tryptophan methyl ester hydrochloride in the test solution, calculate the content of L-tryptophan methyl ester hydrochloride by the area normalization method; The chromatographic conditions are as follows: A chiral chromatographic column Chiralpak IC, 5 μm, 4.6 mm×250 mm, was used, with n-hexane-ethanol-diethylamine in a ratio of 75:25:0.1 as the mobile phase, a flow rate of 1.0 ml per minute, a column temperature of 35° C., and a detection wavelength of 285 nm.

8. The method according to claim 1, It is characterized in that The method comprises the following steps: Step 1, preparation of test solution Take an appropriate amount of D-tryptophan methyl ester hydrochloride sample and add a 1:1 volume ratio of n-hexane-ethanol mixed solvent to make a solution containing 0.5 mg per 1 ml as the test solution; Step 2, preparation of reference solution Take L-tryptophan methyl ester hydrochloride standard, add mobile phase to dissolve and dilute to make a solution containing 0.05 mg per 1 ml, which is used as the chiral impurity location solution; Step 3, Detection Accurately measure 20 μl of chiral impurity localization solution and test solution, respectively, and inject them into the liquid chromatograph, and record the chromatogram until twice the retention time of the main component peak; Step 4, calculate If there is an impurity peak at L-tryptophan methyl ester hydrochloride in the test solution, calculate the content of L-tryptophan methyl ester hydrochloride by the area normalization method; The chromatographic conditions are as follows: A chiral chromatographic column Chiralpak IC, 5 μm, 4.6 mm×250 mm, was used, with n-hexane-isopropanol-diethylamine in a ratio of 60:40:0.1 as the mobile phase, a flow rate of 1.0 ml per minute, a column temperature of 35°C, and a detection wavelength of 285 nm.